The long-term goal is to grow organs for human transplantation.
Category: Editors’ Pick
European Covid-19 Deaths Pass 1 Million In Race Between Vaccines And Variants
The WHO says the situation is “serious” with around 1.6 million new cases reported a week.
‘One Billion Doses On Day One’: Vaccine Company Claims World-Changing Innovation
It’s hard to flawlessly churn out billions of doses of drugs – and we aren’t doing a great job of it. A Midas List VC pulled together a dream team that says it’s come up with a better, faster way.
InnovationRx: Judy Faulkner’s Long Game; Plus J&J Covid-19 Vaccine Pause Extended
InnovationRx is your weekly digest of healthcare news. Sign up!
How The Johnson & Johnson Vaccine Pause Might Slow Down The Global Covid-19 Response
Richer countries have the luxury of picking and choosing between vaccine options, but their regulatory decisions may make it harder for poorer countries to fight the pandemic.
Could Psilocybin Treat Depression? New Head-To-Head Trial Shows It’s At Least As Effective As Leading SSRI
According to a small but rigorous study published in the New England Journal of Medicine, psilocybin could be as effective as a leading antidepressant—and while more research is still required, the study’s lead author says the results should give peopl…
This Startup Raised $25 Million To Liberate Your Healthcare Data In The Cloud
1upHealth is helping health systems and insurers comply with new federal data sharing rules by standardizing and storing medical and claims information.
Biotech R&D Startup Benchling Hits $4 Billion Valuation As The Company Starts Laying Groundwork For An IPO
Sajith Wickramasekara was just 24 when he got on Forbes 30 Under 30 list for his biotech R&D startup Benchling. Now his company is worth $4 billion with a new $200 million round led by Sequoia.
Here’s What Scientists Know About Covid-19 Vaccine Blood Clots, And How The Risks Can Be Diminished
A link to rare blood clots have caused the rollout of the AstraZeneca and Johnson & Johnson Covid-19 vaccines to pause around the world. This is what scientists say about the risks and the next steps.
Johnson & Johnson Covid-19 Vaccine Rollout Is Paused – How Much Should You Worry?
The FDA and CDC announced a pause on the rollout of J&J vaccine out of the old “abundance of caution” following reports of six cases of Cerebral Venous Sinus Thrombosis (CVST). Is this necessary?
